SHPPF (Redcare Pharmacy NV) Beneish M-Score: -2.41 (As of Jun. 24, 2026)


SHPPF Redcare Pharmacy NV SHPPF
65 GF Score
Price $64.80
GF Value $179.18
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Redcare Pharmacy NV Beneish M-Score?

Redcare Pharmacy NV SHPPF 65 Beneish M-Score is -2.41 as of Jun. 24, 2026. GuruFocus rates SHPPF with a GF Score™ of 65/100 and a GF Value™ of $179.18 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 632 Healthcare Providers & Services companies, Redcare Pharmacy NV ranks worse than 64.24% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.41 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Redcare Pharmacy NV's Beneish M-Score or its related term are showing as below:

SHPPF' s Beneish M-Score Range Over the Past 10 Years
Min: -3.63   Med: -2.63   Max: -0.32
Current: -2.41

During the past 13 years, the highest Beneish M-Score of Redcare Pharmacy NV was -0.32. The lowest was -3.63. And the median was -2.63.

Redcare Pharmacy NV Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Redcare Pharmacy NV's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redcare Pharmacy NV Beneish M-Score Chart

Redcare Pharmacy NV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.63 -2.77 -1.04 -2.70 -2.64

Redcare Pharmacy NV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.78 -2.67 -2.63 -2.64 -2.41

Redcare Pharmacy NV Beneish M-Score Competitor Comparison

For the Pharmaceutical Retailers subindustry, Redcare Pharmacy NV's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Redcare Pharmacy NV Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Redcare Pharmacy NV's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Redcare Pharmacy NV's Beneish M-Score falls into.


SHPPF
65GF Score
Redcare Pharmacy NV SHPPF
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Redcare Pharmacy NV Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Redcare Pharmacy NV for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0963+0.528 * 1.051+0.404 * 0.8329+0.892 * 1.3127+0.115 * 1.6551
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8785+4.679 * -0.045807-0.327 * 1.1717
=-2.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was $181 Mil.
Revenue was 982.081 + 931.137 + 844.171 + 817.964 = $3,575 Mil.
Gross Profit was 205.78 + 196.919 + 186.5 + 194.617 = $784 Mil.
Total Current Assets was $670 Mil.
Total Assets was $1,362 Mil.
Property, Plant and Equipment(Net PPE) was $230 Mil.
Depreciation, Depletion and Amortization(DDA) was $81 Mil.
Selling, General, & Admin. Expense(SGA) was $501 Mil.
Total Current Liabilities was $434 Mil.
Long-Term Debt & Capital Lease Obligation was $384 Mil.
Net Income was -12.139 + -33.952 + -8.5 + 10.769 = $-44 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = $0 Mil.
Cash Flow from Operations was 26.012 + -22.036 + -23.722 + 38.328 = $19 Mil.
 Total Receivables was $126 Mil.
Revenue was 775.459 + 706.976 + 637.678 + 603.524 = $2,724 Mil.
Gross Profit was 180.865 + 157.563 + 147.962 + 141.155 = $628 Mil.
Total Current Assets was $556 Mil.
Total Assets was $1,105 Mil.
Property, Plant and Equipment(Net PPE) was $98 Mil.
Depreciation, Depletion and Amortization(DDA) was $74 Mil.
Selling, General, & Admin. Expense(SGA) was $434 Mil.
Total Current Liabilities was $309 Mil.
Long-Term Debt & Capital Lease Obligation was $256 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(180.809 / 3575.353) / (125.634 / 2723.637)
=0.050571 / 0.046127
=1.0963

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(627.545 / 2723.637) / (783.816 / 3575.353)
=0.230407 / 0.219228
=1.051

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (669.711 + 229.595) / 1362.312) / (1 - (556.281 + 97.541) / 1104.537)
=0.339868 / 0.408058
=0.8329

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=3575.353 / 2723.637
=1.3127

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(74.065 / (74.065 + 97.541)) / (80.99 / (80.99 + 229.595))
=0.431599 / 0.260766
=1.6551

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(500.733 / 3575.353) / (434.192 / 2723.637)
=0.140051 / 0.159416
=0.8785

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((383.584 + 433.642) / 1362.312) / ((256.192 + 309.281) / 1104.537)
=0.599882 / 0.511955
=1.1717

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-43.822 - 0 - 18.582) / 1362.312
=-0.045807

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Redcare Pharmacy NV has a M-score of -2.33 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.41 mean?
Redcare Pharmacy NV (SHPPF) has a Beneish M-Score of -2.41 as of Jun. 24, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Redcare Pharmacy NV and its competitors. According to the industry distribution chart, Redcare Pharmacy NV ranks #406 out of 632 companies in the Healthcare Providers & Services industry, placing it in the top 64.2%.
Is Redcare Pharmacy NV's Beneish M-Score too high?
Redcare Pharmacy NV's current Beneish M-Score is -2.41. Based on the distribution chart, Redcare Pharmacy NV ranks #406 out of 632 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Redcare Pharmacy NV has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Redcare Pharmacy NV's Beneish M-Score compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Redcare Pharmacy NV ranks #406 out of 632 companies for Beneish M-Score. This places Redcare Pharmacy NV in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Redcare Pharmacy NV and its competitors. Redcare Pharmacy NV's current Beneish M-Score is -2.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redcare Pharmacy NV stock overvalued right now?
Based on GuruFocus' analysis, Redcare Pharmacy NV (SHPPF) is currently considered Significantly Undervalued. The stock's GF Value™ is $179.18, compared to a current price of $64.80 — trading 63.8% below its estimated fair value. The current Beneish M-Score is -2.41. Redcare Pharmacy NV's overall GF Score™ is 65/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Redcare Pharmacy NV (SHPPF), the current Beneish M-Score is -2.41 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Redcare Pharmacy NV (SHPPF) Overvalued in 2026?

Based on GuruFocus' analysis, Redcare Pharmacy NV stock appears to be undervalued. The current stock price of $64.80 is trading 63.8% below its estimated GF Value™ of $179.18. GuruFocus considers Redcare Pharmacy NV to be Significantly Undervalued.

Key valuation signals for SHPPF:

  • Beneish M-Score: -2.41
  • GF Value™: $179.18 vs. price of $64.80 (63.8% below fair value)
  • GF Score™: 65/100 with 2 warning signs

No single metric tells the full story. See the SHPPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Redcare Pharmacy NV Business Description

Address Erik de Rodeweg 11/13, Sevenum, ZH, NLD, 5975 WD
Redcare Pharmacy NV is an online pharmacy business for prescription and nonprescription (over-the-counter) pharmaceuticals, beauty and personal care products (BPC) and food supplements. Besides OTC, nutritional supplements, beauty and personal care products as well as an extensive assortment of health-related products in all markets, the company also provides prescription drugs for customers in Germany, Switzerland and the Netherlands. It operates in two segments, namely DACH segment that includes sales in Germany, Austria and Switzerland; and the International segment that includes sales across Belgium, the Netherlands, France and Italy. The DACH segment accounts for the majority of the revenue.
65GF Score

Get the complete analysis for SHPPF

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$64.80
Price
$179.18
GF Value